Attenuation	O
of	O
gamma	B-protein
interferon	I-protein
-induced	O
tyrosine	O
phosphorylation	O
in	O
mononuclear	B-cell_type
phagocytes	I-cell_type
infected	O
with	O
Leishmania	O
donovani	O
:	O
selective	O
inhibition	O
of	O
signaling	O
through	O
Janus	B-protein
kinases	I-protein
and	O
Stat1	B-protein
.	O

The	O
induction	O
of	O
gene	O
transcription	O
in	O
response	O
to	O
gamma	B-protein
interferon	I-protein
is	O
impaired	O
in	O
mononuclear	B-cell_type
phagocytes	I-cell_type
infected	O
with	O
Leishmania	O
donovani	O
,	O
and	O
the	O
mechanisms	O
involved	O
are	O
not	O
fully	O
understood	O
.	O

The	O
changes	O
in	O
gene	O
expression	O
brought	O
about	O
by	O
gamma	B-protein
interferon	I-protein
are	O
thought	O
to	O
involve	O
transient	O
increases	O
in	O
the	O
activities	O
of	O
cellular	B-protein
protein	I-protein
tyrosine	I-protein
kinases	I-protein
,	O
including	O
the	O
Janus	B-protein
kinases	I-protein
Jak1	B-protein
and	O
Jak2	B-protein
,	O
leading	O
to	O
tyrosine	O
phosphorylation	O
of	O
the	O
transcription	B-protein
factor	I-protein
Stat1	I-protein
.	O

To	O
investigate	O
the	O
mechanisms	O
accounting	O
for	O
the	O
impaired	O
responses	O
to	O
gamma	B-protein
interferon	I-protein
,	O
a	O
model	O
system	O
for	O
examining	O
overall	O
changes	O
in	O
protein	O
tyrosine	O
phosphorylation	O
,	O
activation	O
of	O
Jak1	B-protein
and	O
Jak2	B-protein
and	O
phosphorylation	O
of	O
Stat1	B-protein
was	O
developed	O
in	O
phorbol	B-cell_line
12-myristate	I-cell_line
13-acetate-differentiated	I-cell_line
U-937	I-cell_line
cells	I-cell_line
.	O

Analysis	O
of	O
whole-cell	O
lysates	O
by	O
antiphosphotyrosine	O
immunoblotting	O
showed	O
that	O
incubation	O
with	O
gamma	B-protein
interferon	I-protein
brought	O
about	O
specific	O
increases	O
in	O
phosphotyrosine	O
labeling	O
of	O
several	O
proteins	O
.	O

Increased	O
labeling	O
of	O
these	O
proteins	O
occurred	O
to	O
similar	O
extents	O
in	O
control	B-cell_type
cells	I-cell_type
and	O
in	O
cells	O
that	O
had	O
been	O
infected	O
with	O
L.	O
donovani	O
for	O
16	O
h	O
.	O

Jak1	B-protein
,	O
Jak2	B-protein
,	O
and	O
Stat1	B-protein
were	O
immunoprecipitated	O
from	O
control	O
and	O
interferon-treated	B-cell_line
cells	I-cell_line
,	O
and	O
tyrosine	O
phosphorylation	O
of	O
these	O
proteins	O
,	O
detected	O
by	O
antiphosphotyrosine	O
immunoblotting	O
was	O
used	O
to	O
measured	O
their	O
activation	O
.	O

Tyrosine	O
phosphorylation	O
of	O
Jak1	B-protein
,	O
Jak2	B-protein
,	O
and	O
Stat1	B-protein
increased	O
markedly	O
,	O
in	O
a	O
dose-dependent	O
manner	O
,	O
in	O
U-937	B-cell_line
cells	I-cell_line
incubated	O
with	O
gamma	B-protein
interferon	I-protein
.	O

In	O
contrast	O
,	O
in	O
cells	O
infected	O
with	O
L.	O
donovani	O
,	O
tyrosine	O
phosphorylation	O
of	O
Jak1	B-protein
,	O
Jak2	B-protein
,	O
and	O
Stat1	B-protein
was	O
markedly	O
impaired	O
.	O

This	O
effect	O
was	O
dependent	O
upon	O
the	O
duration	O
of	O
exposure	O
to	O
L.	O
donovani	O
and	O
was	O
maximal	O
and	O
complete	O
at	O
16	O
h	O
.	O

Results	O
similar	O
to	O
those	O
observed	O
with	O
U-937	B-cell_line
cells	I-cell_line
were	O
also	O
obtained	O
with	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
monocytes	I-cell_type
.	O

These	O
findings	O
indicate	O
that	O
infection	O
of	O
human	B-cell_type
mononuclear	I-cell_type
phagocytes	I-cell_type
with	O
L.	O
donovani	O
leads	O
to	O
impaired	O
gamma	B-protein
interferon	I-protein
-mediated	O
tyrosine	O
phosphorylation	O
and	O
selective	O
effects	O
on	O
the	O
Jak-	O
Stat1	B-protein
pathway	O
.	O

Unresponsiveness	O
to	O
gamma	B-protein
interferon	I-protein
for	O
activation	O
of	O
this	O
pathway	O
may	O
explain	O
impaired	O
transcriptional	O
responses	O
in	O
leishmania-infected	B-cell_type
cells	I-cell_type
.	O

INFECTION	NULL
AND	NULL
IMMUNITY	NULL
,	NULL
Nov.	NULL
1995	NULL
,	NULL
p.	NULL
4495-4500	NULL
0019-9567/95/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1995	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

63	NULL
,	NULL
No	NULL
.	NULL

11	NULL
Attenuation	NULL
of	NULL
Gamma	NULL
Interferon-Induced	NULL
Tyrosine	NULL
Phosphorylation	NULL
in	NULL
Mononuclear	NULL
Phagocytes	NULL
Infected	NULL
with	NULL
Leishmania	NULL
donovani	NULL
:	NULL
Selective	NULL
Inhibition	NULL
of	NULL
Signaling	NULL
through	NULL
Janus	NULL
Kinases	NULL
and	NULL
Statl	NULL
DEVKI	NULL
NANDAN	NULL
aAnp	NULL
NEIL	NULL
E.	NULL
REINER***	NULL
Department	NULL
of	NULL
Medicine	NULL
(	NULL
Division	NULL
of	NULL
Infectious	NULL
Diseases	NULL
)	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
``	NULL
The	NULL
University	NULL
of	NULL
British	NULL
Columbia	NULL
Faculties	NULL
of	NULL
Medicine	NULL
and	NULL
Science	NULL
and	NULL
The	NULL
Research	NULL
Institute	NULL
of	NULL
the	NULL
Vancouver	NULL
Hospital	NULL
and	NULL
Health	NULL
Sciences	NULL
Center	NULL
,	NULL
Vancouver	NULL
,	NULL
British	NULL
Columbia	NULL
,	NULL
Canada	NULL
Received	NULL
28	NULL
June	NULL
1995/Returned	NULL
for	NULL
modification	NULL
15	NULL
August	NULL
1995/Accepted	NULL
31	NULL
August	NULL
1995	NULL
The	NULL
induction	NULL
of	NULL
gene	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
gamma	NULL
interferon	NULL
is	NULL
impaired	NULL
in	NULL
mononuclear	NULL
phagocytes	NULL
infected	NULL
with	NULL
Leishmania	NULL
donovani	NULL
,	NULL
and	NULL
the	NULL
mechanisms	NULL
involved	NULL
are	NULL
not	NULL
fully	NULL
understood	NULL
.	NULL

The	NULL
changes	NULL
in	NULL
gene	NULL
expression	NULL
brought	NULL
about	NULL
by	NULL
gamma	NULL
interferon	NULL
are	NULL
thought	NULL
to	NULL
involve	NULL
transient	NULL
increases	NULL
in	NULL
the	NULL
activities	NULL
of	NULL
cellular	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
,	NULL
including	NULL
the	NULL
Janus	NULL
kinases	NULL
Jakl	NULL
and	NULL
Jak2	NULL
,	NULL
leading	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Stat1	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
mechanisms	NULL
accounting	NULL
for	NULL
the	NULL
impaired	NULL
responses	NULL
to	NULL
gamma	NULL
interferon	NULL
,	NULL
a	NULL
model	NULL
system	NULL
for	NULL
examining	NULL
overall	NULL
changes	NULL
in	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak2	NULL
,	NULL
and	NULL
phosphorylation	NULL
of	NULL
Statl	NULL
was	NULL
developed	NULL
in	NULL
phorbol	NULL
12-myristate	NULL
13-acetate-differentiated	NULL
U-937	NULL
cells	NULL
.	NULL

Analysis	NULL
of	NULL
whole-cell	NULL
lysates	NULL
by	NULL
antiphosphotyrosine	NULL
immunoblotting	NULL
showed	NULL
that	NULL
incubation	NULL
with	NULL
gamma	NULL
interferon	NULL
brought	NULL
about	NULL
specific	NULL
increases	NULL
in	NULL
phosphotyrosine	NULL
labeling	NULL
of	NULL
several	NULL
proteins	NULL
.	NULL

Increased	NULL
labeling	NULL
of	NULL
these	NULL
proteins	NULL
occurred	NULL
to	NULL
similar	NULL
extents	NULL
in	NULL
control	NULL
cells	NULL
and	NULL
in	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
infected	NULL
with	NULL
L.	NULL
donovani	NULL
for	NULL
16	NULL
h.	NULL
Jakl	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Statl	NULL
were	NULL
immunoprecipitated	NULL
from	NULL
control	NULL
and	NULL
interferon-treated	NULL
cells	NULL
,	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
these	NULL
proteins	NULL
,	NULL
detected	NULL
by	NULL
antiphosphotyrosine	NULL
immunoblotting	NULL
,	NULL
was	NULL
used	NULL
to	NULL
measure	NULL
their	NULL
activation	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Statl	NULL
increased	NULL
markedly	NULL
,	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
,	NULL
in	NULL
U-937	NULL
cells	NULL
incubated	NULL
with	NULL
gamma	NULL
interferon	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
cells	NULL
infected	NULL
with	NULL
L.	NULL
donovani	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Statl	NULL
was	NULL
markedly	NULL
impaired	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
dependent	NULL
upon	NULL
the	NULL
duration	NULL
of	NULL
exposure	NULL
to	NULL
L.	NULL
donovani	NULL
and	NULL
was	NULL
maximal	NULL
and	NULL
complete	NULL
at	NULL
16	NULL
h.	NULL
Results	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
with	NULL
U-937	NULL
cells	NULL
were	NULL
also	NULL
obtained	NULL
with	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
infection	NULL
of	NULL
human	NULL
mononuclear	NULL
phagocytes	NULL
with	NULL
L.	NULL
donovani	NULL
leads	NULL
to	NULL
impaired	NULL
gamma	NULL
interferon-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
selective	NULL
effects	NULL
on	NULL
the	NULL
Jak-Stat1	NULL
pathway	NULL
.	NULL

Unresponsiveness	NULL
to	NULL
gamma	NULL
interferon	NULL
for	NULL
activation	NULL
of	NULL
this	NULL
pathway	NULL
may	NULL
explain	NULL
impaired	NULL
transcriptional	NULL
responses	NULL
in	NULL
leishmania-infected	NULL
cells	NULL
.	NULL

Protozoan	NULL
parasites	NULL
of	NULL
the	NULL
genus	NULL
Leishmania	NULL
are	NULL
obligate	NULL
intracellular	NULL
parasites	NULL
of	NULL
monocytes	NULL
and	NULL
macrophages	NULL
that	NULL
cause	NULL
substantial	NULL
human	NULL
morbidity	NULL
and	NULL
mortality	NULL
in	NULL
many	NULL
parts	NULL
of	NULL
the	NULL
world	NULL
.	NULL

An	NULL
important	NULL
question	NULL
in	NULL
mononuclear	NULL
phagocyte	NULL
cell	NULL
biology	NULL
and	NULL
immunology	NULL
is	NULL
how	NULL
leishmanias	NULL
and	NULL
other	NULL
intracellular	NULL
pathogens	NULL
have	NULL
adapted	NULL
to	NULL
resist	NULL
the	NULL
antimicrobial	NULL
properties	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

Mononuclear	NULL
phagocytes	NULL
must	NULL
be	NULL
activated	NULL
to	NULL
kill	NULL
intracellular	NULL
microbes	NULL
,	NULL
and	NULL
while	NULL
a	NULL
broad	NULL
range	NULL
of	NULL
agonists	NULL
are	NULL
able	NULL
to	NULL
bring	NULL
about	NULL
various	NULL
degrees	NULL
of	NULL
cell	NULL
activation	NULL
,	NULL
gamma	NULL
interferon	NULL
is	NULL
the	NULL
most	NULL
thoroughly	NULL
characterized	NULL
agent	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
microbial	NULL
killing	NULL
(	NULL
2	NULL
,	NULL
3	NULL
,	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Infection	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
with	NULL
leishmanias	NULL
and	NULL
other	NULL
intracellular	NULL
pathogens	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
impaired	NULL
cellular	NULL
responsiveness	NULL
to	NULL
gamma	NULL
interferon	NULL
,	NULL
and	NULL
this	NULL
state	NULL
of	NULL
cell	NULL
deactivation	NULL
may	NULL
contribute	NULL
to	NULL
microbial	NULL
persistence	NULL
(	NULL
7	NULL
,	NULL
16	NULL
;	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
14	NULL
)	NULL
.	NULL

While	NULL
the	NULL
exact	NULL
basis	NULL
for	NULL
this	NULL
deactivated	NULL
state	NULL
remains	NULL
to	NULL
be	NULL
fully	NULL
explored	NULL
and	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
multifactorial	NULL
,	NULL
mononuclear	NULL
phagocytes	NULL
infected	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Division	NULL
of	NULL
Infectious	NULL
Dis-eases	NULL
,	NULL
University	NULL
of	NULL
British	NULL
Columbia	NULL
,	NULL
Rm	NULL
.	NULL

452D	NULL
,	NULL
2733	NULL
Heather	NULL
St.	NULL
,	NULL
Vancouver	NULL
,	NULL
British	NULL
Columbia	NULL
,	NULL
Canada	NULL
V5Z	NULL
3J5	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
604	NULL
)	NULL
875-4011	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
604	NULL
)	NULL
875-4013	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
ethan	NULL
@	NULL
unixg.ubc.ca	NULL
.	NULL

4495	NULL
with	NULL
Leishmania	NULL
donovani	NULL
and	NULL
Leishmania	NULL
braziliensis	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
produce	NULL
such	NULL
autoinhibitory	NULL
factors	NULL
as	NULL
prostan-oids	NULL
(	NULL
15	NULL
)	NULL
and	NULL
transforming	NULL
growth	NULL
factor	NULL
B	NULL
(	NULL
1	NULL
)	NULL
that	NULL
attenuate	NULL
cellular	NULL
responses	NULL
to	NULL
gamma	NULL
interferon	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
macrophages	NULL
infected	NULL
with	NULL
L.	NULL
donovani	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
defects	NULL
in	NULL
stimulus-response	NULL
coupling	NULL
,	NULL
leading	NULL
to	NULL
impaired	NULL
functional	NULL
responses	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
14	NULL
)	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
become	NULL
clear	NULL
that	NULL
intracellular	NULL
signaling	NULL
in	NULL
response	NULL
to	NULL
gamma	NULL
interferon	NULL
involves	NULL
two	NULL
cytoplasmic	NULL
tyrosine	NULL
kinases	NULL
that	NULL
are	NULL
members	NULL
of	NULL
the	NULL
Janus	NULL
(	NULL
or	NULL
Jak	NULL
)	NULL
family	NULL
of	NULL
nonreceptor	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
5	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
cells	NULL
with	NULL
gamma	NULL
interferon	NULL
results	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak2	NULL
.	NULL

Activated	NULL
Jaks	NULL
are	NULL
believed	NULL
to	NULL
catalyze	NULL
the	NULL
phosphorylation	NULL
on	NULL
tyrosine	NULL
of	NULL
a	NULL
91,000-M	NULL
,	NULL
DNA-binding	NULL
protein	NULL
known	NULL
as	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
1	NULL
(	NULL
Statl	NULL
)	NULL
.	NULL

Phosphorylated	NULL
Stat1	NULL
dimerizes	NULL
and	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
binds	NULL
to	NULL
the	NULL
gamma	NULL
interferon	NULL
activation	NULL
sequence	NULL
in	NULL
gamma	NULL
interferon-inducible	NULL
genes	NULL
,	NULL
leading	NULL
to	NULL
activation	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

To	NULL
examine	NULL
further	NULL
the	NULL
basis	NULL
for	NULL
unresponsiveness	NULL
of	NULL
leishmania-infected	NULL
macrophages	NULL
to	NULL
gamma	NULL
interferon	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak2	NULL
leading	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
Stat1	NULL
was	NULL
studied	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
gamma	NULL
interferon-induced	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
attenuated	NULL
and	NULL
that	NULL
Jak1	NULL
and	NULL
Jak2	NULL
activation	NULL
and	NULL
phosphorylation	NULL
of	NULL
Statl	NULL
were	NULL
selectively	NULL
impaired	NULL
in	NULL
both	NULL
4496	NULL
NANDAN	NULL
AND	NULL
REINER	NULL
differentiated	NULL
U-937	NULL
cells	NULL
and	NULL
human	NULL
monocytes	NULL
infected	NULL
with	NULL
Leishmania	NULL
donovani	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
and	NULL
chemicals	NULL
.	NULL

RPMI	NULL
1640	NULL
and	NULL
Hanks	NULL
'	NULL
balanced	NULL
salt	NULL
solution	NULL
(	NULL
HBSS	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
Terry	NULL
Fox	NULL
Laboratory	NULL
of	NULL
the	NULL
British	NULL
Columbia	NULL
Cancer	NULL
Agency	NULL
of	NULL
Vancouver	NULL
,	NULL
British	NULL
Columbia	NULL
,	NULL
Canada	NULL
.	NULL

Phorbol	NULL
12-myristate	NULL
13	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
and	NULL
protease	NULL
inhibitors	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
pepstatin	NULL
A	NULL
,	NULL
aprotinin	NULL
,	NULL
and	NULL
leupeptin	NULL
were	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL

Microcystin-LR	NULL
was	NULL
from	NULL
Calbiochem	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
Human	NULL
AB+	NULL
serum	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
Canadian	NULL
Red	NULL
Cross	NULL
,	NULL
Vancouver	NULL
,	NULL
British	NULL
Columbia	NULL
,	NULL
Canada	NULL
.	NULL

Affinity-purified	NULL
antiphosphotyrosine	NULL
monoclonal	NULL
antibody	NULL
4G10	NULL
and	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
to	NULL
Jak1	NULL
and	NULL
Jak2	NULL
were	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
N.Y.	NULL
Rabbit	NULL
polyclonal	NULL
antibodies	NULL
to	NULL
Stat1	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Andrew	NULL
Larner	NULL
,	NULL
The	NULL
Center	NULL
for	NULL
Biologics	NULL
Evaluation	NULL
and	NULL
Research	NULL
,	NULL
Food	NULL
and	NULL
Drug	NULL
Administration	NULL
,	NULL
Bethesda	NULL
,	NULL
Md	NULL
.	NULL

Recombinant	NULL
human	NULL
gamma	NULL
interferon	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Genentech	NULL
Inc.	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
Calif.	NULL
L.	NULL
donovani	NULL
.	NULL

Amastigotes	NULL
of	NULL
the	NULL
Sudan	NULL
strain	NULL
28	NULL
of	NULL
L.	NULL
donovani	NULL
were	NULL
maintained	NULL
by	NULL
serial	NULL
intracardiac	NULL
inoculation	NULL
of	NULL
the	NULL
amastigotes	NULL
into	NULL
female	NULL
Syrian	NULL
hamsters	NULL
.	NULL

The	NULL
amastigotes	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
spleens	NULL
of	NULL
hamsters	NULL
infected	NULL
4	NULL
to	NULL
6	NULL
weeks	NULL
earlier	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Culture	NULL
and	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
.	NULL

The	NULL
promonocytic	NULL
cell	NULL
line	NULL
U-937	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
CRL	NULL
1593	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
suspension	NULL
in	NULL
stationary	NULL
,	NULL
75-em*	NULL
cell	NULL
culture	NULL
flasks	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
low	NULL
endotoxin	NULL
,	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Hy-Clone	NULL
,	NULL
Logan	NULL
,	NULL
Utah	NULL
)	NULL
,	NULL
and	NULL
antibiotics	NULL
as	NULL
described	NULL
for	NULL
human	NULL
monocytes	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Prior	NULL
to	NULL
infection	NULL
with	NULL
L.	NULL
donovani	NULL
U-937	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
18	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

.	NULL

This	NULL
treatment	NULL
rendered	NULL
the	NULL
cells	NULL
adherent	NULL
and	NULL
capable	NULL
of	NULL
phagocytosis	NULL
of	NULL
amastigotes	NULL
.	NULL

Isolation	NULL
and	NULL
culture	NULL
of	NULL
human	NULL
monocytes	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
and	NULL
were	NULL
suspended	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
human	NULL
AB+	NULL
serum	NULL
,	NULL
penicillin	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
,	NULL
and	NULL
streptomycin	NULL
(	NULL
100	NULL
pg/ml	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
seeded	NULL
into	NULL
150-cm	NULL
>	NULL
*	NULL
cell	NULL
culture	NULL
flasks	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1.5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
flask	NULL
.	NULL

Monocytes	NULL
were	NULL
allowed	NULL
to	NULL
adhere	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
-95	NULL
%	NULL
air	NULL
.	NULL

Nonadherent	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
three	NULL
vigorous	NULL
washings	NULL
with	NULL
divalent	NULL
cation-free	NULL
HBSS	NULL
.	NULL

Adherent	NULL
monolayers	NULL
were	NULL
replenished	NULL
with	NULL
supplemented	NULL
RPMI	NULL
1640	NULL
without	NULL
serum	NULL
and	NULL
were	NULL
allowed	NULL
to	NULL
equilibrate	NULL
for	NULL
1	NULL
to	NULL
3	NULL
h	NULL
before	NULL
infection	NULL
.	NULL

Infection	NULL
of	NULL
U-937	NULL
cells	NULL
and	NULL
human	NULL
monocytes	NULL
.	NULL

Differentiated	NULL
U-937	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
75-cm*	NULL
cell	NULL
culture	NULL
flask	NULL
)	NULL
were	NULL
infected	NULL
with	NULL
freshly	NULL
isolated	NULL
amastigotes	NULL
of	NULL
L.	NULL
donovani	NULL
(	NULL
10°	NULL
parasites	NULL
per	NULL
flask	NULL
)	NULL
.	NULL

After	NULL
the	NULL
desired	NULL
period	NULL
of	NULL
incubation	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
-95	NULL
%	NULL
air	NULL
,	NULL
noningested	NULL
amastigotes	NULL
were	NULL
removed	NULL
by	NULL
washing	NULL
with	NULL
HBSS	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
rate	NULL
of	NULL
infection	NULL
,	NULL
cytospin	NULL
preparations	NULL
were	NULL
prepared	NULL
from	NULL
dislodged	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
stained	NULL
with	NULL
Diff-Quik	NULL
.	NULL

For	NULL
the	NULL
infection	NULL
of	NULL
monocytes	NULL
,	NULL
monolayers	NULL
were	NULL
infected	NULL
with	NULL
amastigotes	NULL
at	NULL
a	NULL
parasite-to-monocyte	NULL
ratio	NULL
of	NULL
approximately	NULL
20:1	NULL
.	NULL

The	NULL
rate	NULL
of	NULL
infection	NULL
in	NULL
monocytes	NULL
was	NULL
monitored	NULL
as	NULL
described	NULL
for	NULL
U-937	NULL
cells	NULL
.	NULL

Cell	NULL
incubation	NULL
,	NULL
immunoprecipitation	NULL
,	NULL
and	NULL
Western	NULL
blotting	NULL
(	NULL
immunoblot-ting	NULL
)	NULL
.	NULL

Prior	NULL
to	NULL
treatment	NULL
with	NULL
gamma	NULL
interferon	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
preincubated	NULL
in	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
for	NULL
at	NULL
least	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
an	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
-95	NULL
%	NULL
air	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
cither	NULL
medium	NULL
alone	NULL
or	NULL
the	NULL
desired	NULL
concentration	NULL
of	NULL
gamma	NULL
interferon	NULL
.	NULL

After	NULL
cell	NULL
treatment	NULL
,	NULL
monolayers	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
HBSS	NULL
and	NULL
immediately	NULL
processed	NULL
for	NULL
immunoprecipitation	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak2	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
on	NULL
ice	NULL
in	NULL
modified	NULL
RIPA	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.25	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
,	NULL
0.15	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
[	NULL
ethylene	NULL
glycol-bis	NULL
(	NULL
B-aminoethyl	NULL
ether	NULL
)	NULL
-N	NULL
,	NULL
N	NULL
,	NULL
N	NULL
'	NULL
,	NULL
V'-tet-raacetic	NULL
acid	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
orthovanadate	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
100	NULL
mM	NULL
microcystin	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
2	NULL
g	NULL
of	NULL
pepstatin	NULL
A	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
of	NULL
Stat1l	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
modified	NULL
RIPA	NULL
buffer	NULL
without	NULL
sodium	NULL
deoxycholate	NULL
.	NULL

Lysates	NULL
were	NULL
centrifuged	NULL
in	NULL
a	NULL
microcentrifuge	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
resulting	NULL
supernatants	NULL
were	NULL
transferred	NULL
to	NULL
fresh	NULL
microcentrifuge	NULL
tubes	NULL
and	NULL
incubated	NULL
(	NULL
for	NULL
16	NULL
to	NULL
18	NULL
h	NULL
at	NULL
4°C	NULL
)	NULL
with	NULL
a	NULL
1:250	NULL
dilution	NULL
of	NULL
antibodies	NULL
specific	NULL
for	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
or	NULL
Stat	NULL
]	NULL
or	NULL
with	NULL
normal	NULL
rabbit	NULL
serum	NULL
.	NULL

After	NULL
incubation	NULL
with	NULL
antibodies	NULL
,	NULL
protein	NULL
A-agarose	NULL
was	NULL
added	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
for	NULL
recovery	NULL
of	NULL
immune	NULL
complexes	NULL
.	NULL

The	NULL
protein	NULL
A	NULL
conjugates	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
appropriate	NULL
lysis	NULL
buffer	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
released	NULL
by	NULL
boiling	NULL
agarose	NULL
beads	NULL
in	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
sample	NULL
buffer	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-7.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
this	NULL
was	NULL
followed	NULL
by	NULL
electrophoretic	NULL
transfer	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
.	NULL

The	NULL
unused	NULL
sites	NULL
on	NULL
the	NULL
nitrocellulose	NULL
membranes	NULL
were	NULL
blocked	NULL
with	NULL
3	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
in	NULL
Tris-buffered	NULL
saline-Tween	NULL
20	NULL
(	NULL
TBS-T	NULL
)	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.6	NULL
]	NULL
and	NULL
0.137	NULL
M	NULL
NaCl	NULL
with	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
for	NULL
12	NULL
to	NULL
16	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
a	NULL
10,000-fold	NULL
dilution	NULL
of	NULL
antiphosphotyrosine	NULL
monoclonal	NULL
antibody	NULL
4G10	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
they	NULL
were	NULL
washed	NULL
in	NULL
Tris-buffered	NULL
saline-Tween	NULL
20	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
horseradish	NULL
peroxidase	NULL
conjugates	NULL
of	NULL
secondary	NULL
antibody	NULL
(	NULL
Amersham	NULL
)	NULL
and	NULL
washed	NULL
again	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
immunoblots	NULL
were	NULL
processed	NULL
further	NULL
by	NULL
incubating	NULL
the	NULL
membranes	NULL
with	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
substrate	NULL
,	NULL
and	NULL
the	NULL
immunoblots	NULL
were	NULL
developed	NULL
on	NULL
ECL	NULL
hyperfilm	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
amount	NULL
of	NULL
individual	NULL
INFECT	NULL
.	NULL

ImnmMUN	NULL
.	NULL

NS	NULL
J1	NULL
J2	NULL
J1	NULL
J2	NULL
NS	NULL
7	NULL
8	NULL
far	NULL
*~	NULL
uas	NULL
«	NULL
==	NULL
-STAT1	NULL
10	NULL
203	NULL
4	NULL
5	NULL
6	NULL
Interferon	NULL
-y	NULL
-	NULL
-	NULL
+0	NULL
+	NULL
0+	NULL
B	NULL
_	NULL
JAK1-	NULL
TC	NULL
wen	NULL
mee	NULL
ied	NULL
es	NULL
=	NULL
-JAK2	NULL
102	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Gamma	NULL
interferon-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Stat1	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cells	NULL
were	NULL
treated	NULL
either	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
and	NULL
7	NULL
)	NULL
or	NULL
with	NULL
100	NULL
U	NULL
of	NULL
gamma	NULL
interferon	NULL
per	NULL
ml	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
and	NULL
8	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Lysates	NULL
were	NULL
then	NULL
prepared	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-Jak	NULL
]	NULL
(	NULL
J1	NULL
)	NULL
,	NULL
anti-Jak2	NULL
(	NULL
J2	NULL
)	NULL
,	NULL
anti-Stat1	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
or	NULL
normal	NULL
rabbit	NULL
serum	NULL
(	NULL
NS	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
and	NULL
developed	NULL
by	NULL
ECL	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
a	NULL
constitutively	NULL
expressed	NULL
tyrosine-phosphorylated	NULL
protein	NULL
that	NULL
coprecipitated	NULL
with	NULL
Jak2	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Concentration	NULL
dependence	NULL
of	NULL
gamma	NULL
interferon-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
Jak1	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
and	NULL
Jak2	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
with	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
of	NULL
cytokine	NULL
(	NULL
0	NULL
[	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
]	NULL
,	NULL
1	NULL
[	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
]	NULL
,	NULL
10	NULL
[	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
]	NULL
,	NULL
100	NULL
[	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
]	NULL
,	NULL
and	NULL
1,000	NULL
[	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
]	NULL
U	NULL
of	NULL
gamma	NULL
interferon	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
then	NULL
immunoprecipitated	NULL
with	NULL
either	NULL
anti-Jak1	NULL
or	NULL
anti-Jak2	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
and	NULL
developed	NULL
by	NULL
ECL	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
from	NULL
one	NULL
of	NULL
three	NULL
experiments	NULL
that	NULL
yielded	NULL
similar	NULL
results	NULL
.	NULL

proteins	NULL
immunoprecipitated	NULL
in	NULL
cach	NULL
sample	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
stripped	NULL
after	NULL
the	NULL
chemiluminescence	NULL
detection	NULL
of	NULL
the	NULL
bound	NULL
antiphosphotyrosine	NULL
antibodies	NULL
by	NULL
incubating	NULL
them	NULL
in	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
100	NULL
mM	NULL
B-mercaptocthanol	NULL
,	NULL
and	NULL
62.5	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
for	NULL
45	NULL
min	NULL
at	NULL
50°C	NULL
.	NULL

After	NULL
they	NULL
were	NULL
extensively	NULL
washed	NULL
and	NULL
blocked	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
probed	NULL
with	NULL
anti-Jak1	NULL
,	NULL
anti-Jak2	NULL
,	NULL
or	NULL
anti-Stat1	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
horseradish	NULL
peroxidase	NULL
conjugates	NULL
of	NULL
goat	NULL
anti-rabbit	NULL
(	NULL
Bio-Rad	NULL
)	NULL
immunoglobulin	NULL
G	NULL
,	NULL
and	NULL
the	NULL
blots	NULL
were	NULL
developed	NULL
on	NULL
ECL	NULL
hyperfilm	NULL
by	NULL
ECL	NULL
.	NULL

RESULTS	NULL
Gamma	NULL
interferon	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Stat1	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
Jak-Statl	NULL
signaling	NULL
pathway	NULL
in	NULL
gamma	NULL
interferon-treated	NULL
cells	NULL
,	NULL
exponentially	NULL
growing	NULL
,	NULL
undifferentiated	NULL
U-937	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
with	NULL
either	NULL
medium	NULL
alone	NULL
or	NULL
gamma	NULL
interferon	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
once	NULL
with	NULL
HBSS	NULL
and	NULL
lysed	NULL
in	NULL
detergent	NULL
containing	NULL
RIPA	NULL
lysis	NULL
buffer	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Immunoprecipitation	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
Jak1	NULL
and	NULL
Jak2	NULL
followed	NULL
by	NULL
immunoblot	NULL
analysis	NULL
with	NULL
antiphosphotyrosine	NULL
antibodies	NULL
showed	NULL
that	NULL
gamma	NULL
interferon	NULL
induced	NULL
substantial	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
Jaks	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

It	NULL
should	NULL
also	NULL
be	NULL
noted	NULL
that	NULL
a	NULL
second	NULL
protein	NULL
with	NULL
an	NULL
M	NULL
,	NULL
.	NULL

of	NULL
approximately	NULL
120,000	NULL
that	NULL
appeared	NULL
to	NULL
be	NULL
constitutively	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
was	NULL
consistently	NULL
coim-munoprecipitated	NULL
from	NULL
U-937	NULL
cells	NULL
with	NULL
Jak2	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
this	NULL
constitutively	NULL
phosphorylated	NULL
protein	NULL
is	NULL
unknown	NULL
,	NULL
but	NULL
as	NULL
will	NULL
be	NULL
seen	NULL
below	NULL
,	NULL
it	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak2	NULL
in	NULL
gamma	NULL
interferon-treated	NULL
U-937	NULL
cells	NULL
suggested	NULL
that	NULL
this	NULL
would	NULL
likely	NULL
be	NULL
accompanied	NULL
by	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
DNA-binding	NULL
protein	NULL
Statl	NULL
.	NULL

Immunoprecipitation	NULL
with	NULL
anti-Statl	NULL
followed	NULL
by	NULL
antiphosphotyrosine	NULL
Western	NULL
blotting	NULL
demonstrated	NULL
that	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
a	NULL
protein	NULL
with	NULL
an	NULL
expected	NULL
M	NULL
,	NULL
of	NULL
91,000	NULL
took	NULL
place	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
gamma	NULL
interferon	NULL
dose-response	NULL
relationship	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak2	NULL
,	NULL
U-937	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
with	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
of	NULL
Vou	NULL
.	NULL

63	NULL
,	NULL
1995	NULL
200-	NULL
-	NULL
WW	NULL
)	NULL
__	NULL
wl	NULL
-200-	NULL
_	NULL
|	NULL
J	NULL
.~	NULL
'	NULL
r~	NULL
<	NULL
'=_125	NULL
or-	NULL
4	NULL
week	NULL
16	NULL
®	NULL
<	NULL
p	NULL
~=~~_	NULL
bung	NULL
dai	NULL
duin	NULL
dag	NULL
~	NULL
©0	NULL
-52	NULL
46-30-	NULL
‘	NULL
1	NULL
0203	NULL
4	NULL
5	NULL
6	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
leishmania	NULL
infection	NULL
on	NULL
gamma	NULL
interferon-induced	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

Differentiated	NULL
U-937	NULL
cells	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
incubated	NULL
with	NULL
leishmania	NULL
amastigotes	NULL
at	NULL
an	NULL
approximate	NULL
parasite-to-cell	NULL
ratio	NULL
of	NULL
20:1	NULL
.	NULL

After	NULL
overnight	NULL
incubation	NULL
(	NULL
16	NULL
h	NULL
)	NULL
,	NULL
control	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
and	NULL
infected	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
of	NULL
100	NULL
U	NULL
of	NULL
gamma	NULL
interferon	NULL
per	NULL
ml	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
,	NULL
electrophoresed	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
4G10	NULL
and	NULL
developed	NULL
by	NULL
ECL	NULL
.	NULL

The	NULL
autoluminogram	NULL
of	NULL
a	NULL
blot	NULL
is	NULL
shown	NULL
,	NULL
with	NULL
the	NULL
molecular	NULL
masses	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
of	NULL
the	NULL
marker	NULL
proteins	NULL
on	NULL
the	NULL
left	NULL
.	NULL

The	NULL
relative	NULL
electrophoretic	NULL
mobilities	NULL
of	NULL
the	NULL
proteins	NULL
of	NULL
interest	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
in	NULL
kilodaltons	NULL
.	NULL

Lanes	NULL
5	NULL
and	NULL
6	NULL
show	NULL
phosphotyrosine-containing	NULL
proteins	NULL
in	NULL
a	NULL
direct	NULL
cell	NULL
lysate	NULL
of	NULL
amastigotes	NULL
.	NULL

Lanes	NULL
5	NULL
and	NULL
6	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
loaded	NULL
with	NULL
2	NULL
X	NULL
10°	NULL
and	NULL
10	NULL
``	NULL
amastigotes	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
from	NULL
one	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
that	NULL
yielded	NULL
similar	NULL
results	NULL
.	NULL

cytokine	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
demonstrate	NULL
that	NULL
phosphorylation	NULL
of	NULL
both	NULL
Jak1	NULL
and	NULL
Jak2	NULL
was	NULL
detectable	NULL
at	NULL
10	NULL
U	NULL
of	NULL
gamma	NULL
interferon	NULL
per	NULL
ml	NULL
and	NULL
was	NULL
maximal	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
100	NULL
U/ml	NULL
.	NULL

Effect	NULL
of	NULL
leishmania	NULL
infection	NULL
on	NULL
gamma	NULL
interferon-induced	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

Incubation	NULL
of	NULL
exponentially	NULL
growing	NULL
U-937	NULL
cells	NULL
with	NULL
Leishmania	NULL
amastigotes	NULL
resulted	NULL
in	NULL
infection	NULL
of	NULL
only	NULL
10	NULL
to	NULL
20	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
U-937	NULL
cells	NULL
were	NULL
allowed	NULL
to	NULL
differentiate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
24	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
became	NULL
adherent	NULL
,	NULL
and	NULL
upon	NULL
incubation	NULL
with	NULL
Leishmania	NULL
amastigotes	NULL
,	NULL
infection	NULL
rates	NULL
of	NULL
>	NULL
90	NULL
%	NULL
were	NULL
achieved	NULL
.	NULL

In	NULL
initial	NULL
studies	NULL
,	NULL
responses	NULL
of	NULL
phorbol	NULL
ester-differentiated	NULL
U-937	NULL
cells	NULL
to	NULL
gamma	NULL
interferon	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak2	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Statl	NULL
were	NULL
observed	NULL
to	NULL
be	NULL
indistinguishable	NULL
from	NULL
those	NULL
observed	NULL
in	NULL
nondifferentiated	NULL
cells	NULL
.	NULL

Differentiated	NULL
U-937	NULL
cells	NULL
were	NULL
,	NULL
therefore	NULL
,	NULL
considered	NULL
to	NULL
be	NULL
a	NULL
suitable	NULL
model	NULL
system	NULL
in	NULL
which	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
infection	NULL
with	NULL
L.	NULL
donovani	NULL
,	NULL
and	NULL
these	NULL
cells	NULL
were	NULL
used	NULL
in	NULL
all	NULL
studies	NULL
concerned	NULL
with	NULL
leishmania	NULL
infection	NULL
.	NULL

Differentiated	NULL
U-937	NULL
cells	NULL
,	NULL
infected	NULL
and	NULL
noninfected	NULL
,	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
incubated	NULL
with	NULL
gamma	NULL
interferon	NULL
(	NULL
100	NULL
U/ml	NULL
!	NULL
)	NULL

for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
this	NULL
was	NULL
followed	NULL
by	NULL
lysis	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
.	NULL

Lysates	NULL
were	NULL
analyzed	NULL
by	NULL
antiphosphotyrosine	NULL
Western	NULL
blotting	NULL
.	NULL

Basal	NULL
(	NULL
in	NULL
non-interferon-treated	NULL
cells	NULL
)	NULL
patterns	NULL
of	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
were	NULL
different	NULL
for	NULL
control	NULL
and	NULL
leishmania-infected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
;	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
a	NULL
prominent	NULL
band	NULL
with	NULL
an	NULL
M	NULL
,	NULL
.	NULL

of	NULL
approximately	NULL
200,000	NULL
was	NULL
present	NULL
with	NULL
infected	NULL
cells	NULL
but	NULL
not	NULL
with	NULL
control	NULL
cells	NULL
.	NULL

In	NULL
order	NULL
to	NULL
ascertain	NULL
to	NULL
what	NULL
extent	NULL
amastigote-derived	NULL
proteins	NULL
may	NULL
have	NULL
contributed	NULL
to	NULL
the	NULL
differences	NULL
ob-served	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
in	NULL
an	NULL
amastigote	NULL
lysate	NULL
was	NULL
examined	NULL
in	NULL
parallel	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
a	NULL
prominent	NULL
protein	NULL
band	NULL
with	NULL
an	NULL
M	NULL
,	NULL
of	NULL
200,000	NULL
was	NULL
also	NULL
observed	NULL
with	NULL
the	NULL
amastigote	NULL
preparation	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
the	NULL
corresponding	NULL
band	NULL
in	NULL
infected	NULL
cells	NULL
was	NULL
likely	NULL
leishmania	NULL
derived	NULL
and	NULL
not	NULL
an	NULL
induced	NULL
host	NULL
cell	NULL
protein	NULL
.	NULL

Of	NULL
LEISHMANIA	NULL
DONOVANI	NULL
AND	NULL
Jak-Statl	NULL
SIGNALING	NULL
4497	NULL
A	NULL
q	NULL
or	NULL
s	NULL
:	NULL
4	NULL
s	NULL
s	NULL
tos	NULL
«	NULL
n	NULL
@	NULL
-	NULL
-	NULL
om	NULL
_	NULL
an	NULL
9	NULL
10	NULL
11	NULL
12	NULL
d	NULL
sas	NULL
see	NULL
--	NULL
JAK1	NULL
--	NULL
--	NULL
JAK2-	NULL
_	NULL
-	NULL
STATI	NULL
--	NULL
B	NULL
haunt—Li	NULL
7-H	NULL
‘	NULL
hdu	NULL
Ff	NULL
‘	NULL
f	NULL
‘	NULL
u	NULL
“	NULL
?	NULL

#	NULL
s	NULL
_	NULL
boalh	NULL
Mos	NULL
hil	NULL
EA	NULL
&	NULL
Lt	NULL
fis	NULL
s	NULL
``	NULL
1	NULL
2	NULL
3	NULL
40	NULL
5	NULL
60	NULL
ToB	NULL
9	NULL
40	NULL
11	NULL
12	NULL
--	NULL
JAK1	NULL
--	NULL
-	NULL
--	NULL
JAK2	NULL
--	NULL
00	NULL
-STAM	NULL
--	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Leishmania	NULL
infection	NULL
attenuates	NULL
gamma	NULL
interferon-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Stat1	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

Differentiated	NULL
U-937	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
amastigotes	NULL
of	NULL
L.	NULL
donovani	NULL
at	NULL
an	NULL
approximate	NULL
parasite-to-cell	NULL
ratio	NULL
of	NULL
20:1	NULL
.	NULL

Parallel	NULL
flasks	NULL
were	NULL
incubated	NULL
with	NULL
fixed	NULL
S.	NULL
aureus	NULL
(	NULL
0.002	NULL
%	NULL
)	NULL
.	NULL

After	NULL
overnight	NULL
incubation	NULL
(	NULL
16	NULL
h	NULL
)	NULL
,	NULL
control	NULL
and	NULL
infected	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
HBBS	NULL
and	NULL
incubated	NULL
with	NULL
gamma	NULL
interferon	NULL
(	NULL
100	NULL
U/m	NULL
!	NULL
)	NULL

for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
lysed	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
antibodies	NULL
indicated	NULL
.	NULL

Immunoprecipitated	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
an	NULL
SDS-polyacrylamide	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
,	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
antibodies	NULL
,	NULL
and	NULL
developed	NULL
by	NULL
ECL	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Anti-Jak1	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
,	NULL
anti-Jak2	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
,	NULL
and	NULL
anti-Stat1	NULL
(	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
)	NULL
.	NULL

Lanes	NULL
1	NULL
,	NULL
5	NULL
,	NULL
and	NULL
9	NULL
are	NULL
controls	NULL
(	NULL
uninfected	NULL
and	NULL
with	NULL
no	NULL
gamma	NULL
interferon	NULL
.	NULL

Lanes	NULL
2	NULL
,	NULL
6	NULL
,	NULL
and	NULL
10	NULL
represent	NULL
uninfected	NULL
cells	NULL
incubated	NULL
with	NULL
gamma	NULL
interferon	NULL
.	NULL

Lanes	NULL
3	NULL
,	NULL
7	NULL
,	NULL
and	NULL
11	NULL
are	NULL
infected	NULL
cells	NULL
incubated	NULL
with	NULL
gamma	NULL
interferon	NULL
.	NULL

Lanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
12	NULL
represent	NULL
cells	NULL
that	NULL
had	NULL
ingested	NULL
8.	NULL
aureus	NULL
before	NULL
incubation	NULL
with	NULL
gamma	NULL
interferon	NULL
16	NULL
h	NULL
later	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
same	NULL
membrane	NULL
,	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-Jak1	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
,	NULL
anti-Jak2	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
,	NULL
and	NULL
anti-Stat1	NULL
(	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
)	NULL
and	NULL
developed	NULL
by	NULL
ECL	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
from	NULL
one	NULL
of	NULL
three	NULL
experiments	NULL
that	NULL
yielded	NULL
similar	NULL
results	NULL
.	NULL

interest	NULL
was	NULL
that	NULL
some	NULL
leishmania-derived	NULL
phosphotyrosine-containing	NULL
proteins-for	NULL
example	NULL
,	NULL
the	NULL
prominent	NULL
doublet	NULL
with	NULL
Ms	NULL
of	NULL
approximately	NULL
76,000	NULL
and	NULL
72,000-actually	NULL
appeared	NULL
to	NULL
be	NULL
diminished	NULL
in	NULL
intensity	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

Treatment	NULL
of	NULL
noninfected	NULL
control	NULL
cells	NULL
with	NULL
gamma	NULL
interferon	NULL
brought	NULL
about	NULL
increased	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
at	NULL
least	NULL
three	NULL
proteins	NULL
with	NULL
Ms	NULL
of	NULL
approximately	NULL
125,000	NULL
,	NULL
60,000	NULL
,	NULL
and	NULL
52,000	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
;	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Increased	NULL
labeling	NULL
of	NULL
these	NULL
proteins	NULL
also	NULL
occurred	NULL
to	NULL
a	NULL
comparable	NULL
extent	NULL
in	NULL
leishmania-infected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
;	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
leishmania	NULL
infection	NULL
does	NULL
not	NULL
globally	NULL
inhibit	NULL
gamma	NULL
interferon-induced	NULL
changes	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

Gamma	NULL
interferon-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Statl	NULL
is	NULL
attenuated	NULL
in	NULL
leishmania-infected	NULL
U-937	NULL
cells	NULL
.	NULL

Differentiated	NULL
U-937	NULL
cells	NULL
,	NULL
infected	NULL
(	NULL
for	NULL
16	NULL
to	NULL
18	NULL
h	NULL
)	NULL
and	NULL
noninfected	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
gamma	NULL
interferon	NULL
and	NULL
analyzed	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Statl	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
gamma	NULL
interferon-induced	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
(	NULL
panel	NULL
A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
,	NULL
Jak2	NULL
(	NULL
panel	NULL
A	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
,	NULL
and	NULL
Stat1	NULL
(	NULL
panel	NULL
A	NULL
,	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
)	NULL
appeared	NULL
to	NULL
be	NULL
abrogated	NULL
in	NULL
Leishmania-infected	NULL
cells	NULL
.	NULL

To	NULL
control	NULL
for	NULL
the	NULL
non-specific	NULL
effects	NULL
of	NULL
phagocytosis	NULL
,	NULL
an	NULL
additional	NULL
group	NULL
of	NULL
U-937	NULL
cells	NULL
was	NULL
allowed	NULL
to	NULL
ingest	NULL
fixed	NULL
Staphylococcus	NULL
aureus	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
(	NULL
panel	NULL
A	NULL
,	NULL
lanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
12	NULL
)	NULL
,	NULL
these	NULL
cells	NULL
were	NULL
fully	NULL
responsive	NULL
to	NULL
gamma	NULL
interferon	NULL
.	NULL

The	NULL
simplest	NULL
explanation	NULL
for	NULL
decreased	NULL
signal	NULL
intensity	NULL
in	NULL
samples	NULL
from	NULL
Leishmania	NULL
-infected	NULL
cells	NULL
in	NULL
the	NULL
4G10	NULL
antiphosphotyrosine	NULL
immunoblots	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
is	NULL
impaired	NULL
gamma	NULL
interferon-induced	NULL
signaling	NULL
.	NULL

This	NULL
would	NULL
result	NULL
in	NULL
the	NULL
diminished	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak2	NULL
,	NULL
in	NULL
the	NULL
decreased	NULL
autophosphorylation	NULL
of	NULL
these	NULL
kinases	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
diminished	NULL
phosphorylation	NULL
of	NULL
Statl	NULL
.	NULL

Alternatively	NULL
,	NULL
these	NULL
results	NULL
could	NULL
also	NULL
be	NULL
explained	NULL
if	NULL
infection	NULL
had	NULL
in	NULL
some	NULL
manner	NULL
led	NULL
to	NULL
reduced	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
these	NULL
three	NULL
proteins	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
however	NULL
,	NULL
the	NULL
latter	NULL
possibility	NULL
was	NULL
eliminated	NULL
when	NULL
the	NULL
membranes	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Statl	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
,	NULL
relative	NULL
to	NULL
those	NULL
in	NULL
the	NULL
4498	NULL
NANDAN	NULL
AND	NULL
REINER	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
60	NULL
7	NULL
8	NULL
=	NULL
9	NULL
sare	NULL
-	NULL
poms	NULL
pag	NULL
fome	NULL
font	NULL
tam	NULL
toe	NULL
(	NULL
tt	NULL
,	NULL
_	NULL
,	NULL
4	NULL
<	NULL
Infection	NULL
so	NULL
&	NULL
9	NULL
#	NULL
+0	NULL
#	NULL
n	NULL
#	NULL
Interferon	NULL
4	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
_C	NULL
!	NULL

Time	NULL
(	NULL
hr	NULL
)	NULL
3	NULL
5	NULL
7	NULL
16	NULL
5	NULL
%	NULL
Infection	NULL
0	NULL
5	NULL
10	NULL
15	NULL
20	NULL
Duration	NULL
of	NULL
Infection	NULL
(	NULL
hr	NULL
)	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Kinetic	NULL
analysis	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
leishmania	NULL
infection	NULL
on	NULL
gamma	NULL
interferon-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

Differentiated	NULL
U-937	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
amastigotes	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
and	NULL
were	NULL
subsequently	NULL
incubated	NULL
with	NULL
gamma	NULL
interferon	NULL
(	NULL
100	NULL
U/ml	NULL
!	NULL
)	NULL

for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Lysates	NULL
were	NULL
prepared	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-Jak2	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
and	NULL
developed	NULL
by	NULL
ECL	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Autoluminogram	NULL
of	NULL
blot	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Histogram	NULL
showing	NULL
the	NULL
frequency	NULL
of	NULL
infected	NULL
cells	NULL
as	NULL
a	NULL
function	NULL
of	NULL
duration	NULL
of	NULL
exposure	NULL
to	NULL
amastigotes	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
from	NULL
one	NULL
experiment	NULL
.	NULL

control	NULL
cells	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
all	NULL
three	NULL
proteins	NULL
in	NULL
the	NULL
infected	NULL
cells	NULL
were	NULL
not	NULL
reduced	NULL
.	NULL

Attenuation	NULL
of	NULL
Jak-Stat	NULL
signaling	NULL
during	NULL
leishmania	NULL
infection	NULL
is	NULL
time	NULL
dependent	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
effects	NULL
of	NULL
leishmania	NULL
infection	NULL
were	NULL
time	NULL
dependent	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
amastigotes	NULL
for	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

The	NULL
incu-bations	NULL
were	NULL
then	NULL
terminated	NULL
by	NULL
lysis	NULL
in	NULL
RIPA	NULL
buffer	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
processed	NULL
for	NULL
immunoprecipitation	NULL
and	NULL
immunob-lotting	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
gamma	NULL
interferon-induced	NULL
activation	NULL
of	NULL
the	NULL
Jak-Stat	NULL
pathway	NULL
occurred	NULL
normally	NULL
through	NULL
7	NULL
h	NULL
of	NULL
infection	NULL
(	NULL
80	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
7.9	NULL
+	NULL
4.4	NULL
[	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
]	NULL
amastigotes	NULL
per	NULL
cell	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
by	NULL
16	NULL
h	NULL
(	NULL
90	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
infected	NULL
with	NULL
15	NULL
+	NULL
8	NULL
amastigotes	NULL
per	NULL
cell	NULL
)	NULL
,	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
Jak-Stat	NULL
pathway	NULL
.	NULL

Leishmania	NULL
infection	NULL
attenuates	NULL
interferon-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1l	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Statl	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
above	NULL
indicate	NULL
that	NULL
infection	NULL
of	NULL
differentiated	NULL
U-937	NULL
cells	NULL
with	NULL
L.	NULL
donovani	NULL
induces	NULL
a	NULL
state	NULL
of	NULL
unresponsiveness	NULL
to	NULL
gamma	NULL
interferon-mediated	NULL
signaling	NULL
through	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Stat1	NULL
.	NULL

To	NULL
validate	NULL
differentiated	NULL
U-937	NULL
cells	NULL
as	NULL
a	NULL
model	NULL
system	NULL
in	NULL
which	NULL
to	NULL
study	NULL
this	NULL
interaction	NULL
further	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
L.	NULL
donovani	NULL
infection	NULL
on	NULL
gamma	NULL
interferon	NULL
signaling	NULL
were	NULL
also	NULL
examined	NULL
in	NULL
primary	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

Monocyte	NULL
monolayers	NULL
were	NULL
incubated	NULL
with	NULL
freshly	NULL
isolated	NULL
amastigotes	NULL
of	NULL
L.	NULL
donovani	NULL
at	NULL
a	NULL
parasite	NULL
to-cell	NULL
ratio	NULL
of	NULL
approximately	NULL
20:1	NULL
.	NULL

This	NULL
resulted	NULL
in	NULL
an	NULL
infection	NULL
rate	NULL
of	NULL
>	NULL
95	NULL
%	NULL
at	NULL
approximately	NULL
9.1	NULL
+	NULL
5.3	NULL
(	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
)	NULL
amastigotes	NULL
per	NULL
cell	NULL
.	NULL

After	NULL
16	NULL
to	NULL
18	NULL
h	NULL
of	NULL
incubation	NULL
,	NULL
infected	NULL
and	NULL
control	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
gamma	NULL
interferon	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
and	NULL
processed	NULL
for	NULL
immunoprecipitation	NULL
and	NULL
antiphosphotyrosine	NULL
Western	NULL
blot	NULL
INFECT	NULL
.	NULL

ImnmMUN	NULL
.	NULL

JAK1	NULL
-	NULL
``	NULL
*~	NULL
``	NULL
__	NULL
_-JAK2	NULL
s	NULL
-STAT1	NULL
1°	NULL
20	NULL
3	NULL
4	NULL
5	NULL
6	NULL
T	NULL
8	NULL
°9	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Leishmania	NULL
infection	NULL
attenuates	NULL
gamma	NULL
interferon-induced	NULL
Jak-Stat	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Monolayers	NULL
of	NULL
freshly	NULL
isolated	NULL
human	NULL
monocytes	NULL
were	NULL
cither	NULL
left	NULL
untreated	NULL
or	NULL
exposed	NULL
to	NULL
amastigotes	NULL
at	NULL
an	NULL
approximate	NULL
parasite-to-cell	NULL
ratio	NULL
of	NULL
20:1	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Sixteen	NULL
hours	NULL
later	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
gamma	NULL
interferon	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
then	NULL
prepared	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-Jak1	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
,	NULL
anti-Jak2	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
,	NULL
and	NULL
anti-Stat1	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
separated	NULL
on	NULL
an	NULL
SDS-polyacrylamide	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
,	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
antibodies	NULL
,	NULL
and	NULL
developed	NULL
by	NULL
ECL	NULL
.	NULL

Lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
are	NULL
control	NULL
cells	NULL
(	NULL
uninfected	NULL
and	NULL
with	NULL
no	NULL
gamma	NULL
interferon	NULL
)	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
are	NULL
uninfected	NULL
cells	NULL
incubated	NULL
with	NULL
gamma	NULL
interferon	NULL
,	NULL
and	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
are	NULL
infected	NULL
cells	NULL
incubated	NULL
with	NULL
gamma	NULL
interferon	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
from	NULL
one	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
that	NULL
yielded	NULL
similar	NULL
results	NULL
.	NULL

ting	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
demonstrate	NULL
that-as	NULL
was	NULL
the	NULL
case	NULL
with	NULL
differentiated	NULL
U-937	NULL
cells-leishmania	NULL
infection	NULL
induces	NULL
a	NULL
state	NULL
of	NULL
unresponsiveness	NULL
to	NULL
gamma	NULL
interferon	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak2	NULL
and	NULL
for	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Statl	NULL
.	NULL

DISCUSSION	NULL
Mononuclear	NULL
phagocytes	NULL
infected	NULL
with	NULL
L.	NULL
donovani	NULL
have	NULL
impaired	NULL
responses	NULL
to	NULL
gamma	NULL
interferon	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
gene	NULL
transcription	NULL
(	NULL
7	NULL
,	NULL
14	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
aim	NULL
of	NULL
the	NULL
present	NULL
study	NULL
was	NULL
to	NULL
investigate	NULL
the	NULL
possibility	NULL
that	NULL
this	NULL
state	NULL
of	NULL
diminished	NULL
responsiveness	NULL
may	NULL
be	NULL
related	NULL
to	NULL
defective	NULL
gamma	NULL
interferon-mediated	NULL
cell	NULL
signaling	NULL
.	NULL

Agonist-mediated	NULL
changes	NULL
in	NULL
the	NULL
activities	NULL
of	NULL
both	NULL
receptor	NULL
and	NULL
nonreceptor	NULL
tyrosine	NULL
kinases	NULL
are	NULL
known	NULL
to	NULL
play	NULL
central	NULL
roles	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
function	NULL
(	NULL
5	NULL
,	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
a	NULL
direct	NULL
pathway	NULL
leading	NULL
from	NULL
the	NULL
gamma	NULL
interferon	NULL
receptor	NULL
to	NULL
activation	NULL
of	NULL
gene	NULL
transcription	NULL
is	NULL
now	NULL
known	NULL
to	NULL
involve	NULL
two	NULL
members	NULL
of	NULL
the	NULL
Janus	NULL
family	NULL
of	NULL
cytoplasmic	NULL
tyrosine	NULL
kinases	NULL
,	NULL
Jak1	NULL
and	NULL
Jak2	NULL
,	NULL
and	NULL
in	NULL
addition	NULL
,	NULL
the	NULL
latent	NULL
cytoplasmic	NULL
DNA-binding	NULL
protein	NULL
Stat1	NULL
(	NULL
5	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
Jak	NULL
kinases	NULL
involves	NULL
their	NULL
autophosphorylation	NULL
on	NULL
tyrosine	NULL
,	NULL
and	NULL
Jak1	NULL
and	NULL
Jak2	NULL
appear	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
bringing	NULL
about	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat1	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Tyrosine-phosphorylated	NULL
Statl	NULL
dimerizes	NULL
through	NULL
SH2	NULL
domain	NULL
interactions	NULL
and	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
binds	NULL
to	NULL
a	NULL
specific	NULL
DNA	NULL
consensus	NULL
sequence	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
gamma	NULL
interferon	NULL
activation	NULL
sequence	NULL
,	NULL
present	NULL
within	NULL
promoter	NULL
regions	NULL
of	NULL
certain	NULL
gamma	NULL
interferon-inducible	NULL
genes	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
regulation	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
at	NULL
the	NULL
whole-cell	NULL
level	NULL
and	NULL
specifically	NULL
the	NULL
Jak-Stat	NULL
signaling	NULL
pathway	NULL
are	NULL
logical	NULL
targets	NULL
upon	NULL
which	NULL
to	NULL
focus	NULL
an	NULL
investigation	NULL
of	NULL
impaired	NULL
responses	NULL
to	NULL
gamma	NULL
interferon	NULL
during	NULL
leishmania	NULL
infection	NULL
.	NULL

In	NULL
initial	NULL
experiments	NULL
,	NULL
it	NULL
was	NULL
observed	NULL
that	NULL
treatment	NULL
of	NULL
undifferentiated	NULL
U-937	NULL
cells	NULL
with	NULL
gamma	NULL
interferon	NULL
resulted	NULL
in	NULL
rapid	NULL
increases	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Statl	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
,	NULL
and	NULL
this	NULL
was	NULL
found	NULL
to	NULL
be	NULL
concentration	NULL
dependent	NULL
for	NULL
gamma	NULL
interferon	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
because	NULL
these	NULL
cells	NULL
ingested	NULL
L.	NULL
donovani	NULL
only	NULL
to	NULL
a	NULL
limited	NULL
extent	NULL
,	NULL
it	NULL
was	NULL
necessary	NULL
to	NULL
differentiate	NULL
them	NULL
with	NULL
PMA	NULL
,	NULL
after	NULL
which	NULL
they	NULL
became	NULL
adherent	NULL
and	NULL
were	NULL
readily	NULL
infected	NULL
with	NULL
L.	NULL
donovani	NULL
.	NULL

The	NULL
Jak-Stat	NULL
pathway	NULL
was	NULL
also	NULL
observed	NULL
to	NULL
be	NULL
rapidly	NULL
activated	NULL
in	NULL
PMA-differentiated	NULL
U-937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
the	NULL
responses	NULL
observed	NULL
in	NULL
differentiated	NULL
U-937	NULL
cells	NULL
were	NULL
indistinguishable	NULL
from	NULL
those	NULL
observed	NULL
in	NULL
non-PMA-treated	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
differentiated	NULL
Vou	NULL
.	NULL

63	NULL
,	NULL
1995	NULL
U-937	NULL
cells	NULL
are	NULL
a	NULL
suitable	NULL
model	NULL
system	NULL
in	NULL
which	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
L.	NULL
donovani	NULL
on	NULL
gamma	NULL
interferon-regulated	NULL
changes	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
at	NULL
the	NULL
whole-cell	NULL
level	NULL
as	NULL
well	NULL
as	NULL
on	NULL
the	NULL
more	NULL
specific	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak2	NULL
leading	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
Statl	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
a	NULL
constitutive	NULL
phosphotyrosine-containing	NULL
protein	NULL
with	NULL
a	NULL
slightly	NULL
lower	NULL
molecular	NULL
mass	NULL
than	NULL
that	NULL
of	NULL
Jak2	NULL
was	NULL
consistently	NULL
coim-munoprecipitated	NULL
with	NULL
Jak2	NULL
in	NULL
U-937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
to	NULL
4	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
this	NULL
protein	NULL
is	NULL
not	NULL
known	NULL
,	NULL
but	NULL
it	NULL
may	NULL
not	NULL
be	NULL
unique	NULL
to	NULL
this	NULL
system	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
constitutively	NULL
phosphotyrosine-containing	NULL
protein	NULL
with	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
Jak2	NULL
was	NULL
also	NULL
observed	NULL
to	NULL
be	NULL
present	NULL
in	NULL
Jak2	NULL
immunoprecipitates	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
overall	NULL
basal	NULL
patterns	NULL
of	NULL
phosphotyrosine-containing	NULL
proteins	NULL
in	NULL
whole-cell	NULL
lysates	NULL
were	NULL
different	NULL
for	NULL
noninfected	NULL
and	NULL
infected	NULL
U-937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
a	NULL
prominent	NULL
band	NULL
with	NULL
an	NULL
M	NULL
,	NULL
of	NULL
approximately	NULL
200,000	NULL
was	NULL
present	NULL
in	NULL
infected	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
control	NULL
cells	NULL
.	NULL

A	NULL
phosphotyrosine-containing	NULL
protein	NULL
with	NULL
an	NULL
M	NULL
,	NULL
of	NULL
200,000	NULL
was	NULL
also	NULL
relatively	NULL
abundant	NULL
in	NULL
4G10	NULL
immunoblots	NULL
of	NULL
amastigote	NULL
lysates	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
corresponding	NULL
band	NULL
in	NULL
infected	NULL
cells	NULL
was	NULL
likely	NULL
leishmania	NULL
derived	NULL
and	NULL
not	NULL
an	NULL
induced	NULL
host	NULL
cell	NULL
protein	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
two	NULL
other	NULL
prominent	NULL
phosphotyrosine-containing	NULL
proteins	NULL
that	NULL
were	NULL
also	NULL
observed	NULL
in	NULL
amastigotes	NULL
and	NULL
that	NULL
had	NULL
M	NULL
,	NULL
of	NULL
approximately	NULL
72,000	NULL
and	NULL
76,000	NULL
were	NULL
significantly	NULL
diminished	NULL
in	NULL
intensity	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
leishmania-derived	NULL
phosphotyrosine-containing	NULL
proteins	NULL
are	NULL
differentially	NULL
expressed	NULL
in	NULL
infected	NULL
macrophages	NULL
.	NULL

There	NULL
are	NULL
several	NULL
possible	NULL
explanations	NULL
for	NULL
this	NULL
finding	NULL
.	NULL

First	NULL
,	NULL
this	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
differential	NULL
synthesis	NULL
or	NULL
stabilities	NULL
of	NULL
these	NULL
amastigote	NULL
proteins	NULL
within	NULL
U-937	NULL
cells	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
activities	NULL
of	NULL
leishmania	NULL
tyrosine	NULL
kinases	NULL
,	NULL
phosphotyrosine	NULL
phosphatases	NULL
or	NULL
both	NULL
towards	NULL
these	NULL
proteins	NULL
may	NULL
be	NULL
differentially	NULL
regulated	NULL
in	NULL
amastigotes	NULL
and	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

Third	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
a	NULL
host	NULL
cell	NULL
phosphatase	NULL
may	NULL
have	NULL
greater	NULL
activity	NULL
toward	NULL
the	NULL
72,000-	NULL
and	NULL
76,000-M	NULL
,	NULL
leishmania	NULL
proteins	NULL
compared	NULL
with	NULL
that	NULL
toward	NULL
the	NULL
200,000-M	NULL
,	NULL
phosphotyrosine-containing	NULL
protein	NULL
.	NULL

Further	NULL
work	NULL
will	NULL
be	NULL
required	NULL
to	NULL
identify	NULL
these	NULL
leishmania	NULL
phosphotyrosine-containing	NULL
proteins	NULL
and	NULL
to	NULL
define	NULL
their	NULL
potential	NULL
roles	NULL
in	NULL
disease	NULL
pathogenesis	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
patterns	NULL
of	NULL
phosphotyrosine-containing	NULL
proteins	NULL
in	NULL
U-937	NULL
whole-cell	NULL
lysates	NULL
indicated	NULL
that	NULL
at	NULL
least	NULL
three	NULL
proteins	NULL
with	NULL
M	NULL
,	NULL
s	NULL
of	NULL
approximately	NULL
125,000	NULL
,	NULL
60,000	NULL
,	NULL
and	NULL
52,000	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
showed	NULL
increased	NULL
phosphotyrosine	NULL
content	NULL
after	NULL
incubation	NULL
with	NULL
gamma	NULL
interferon	NULL
.	NULL

Notably	NULL
,	NULL
increased	NULL
labeling	NULL
of	NULL
these	NULL
proteins	NULL
occurred	NULL
to	NULL
similar	NULL
extents	NULL
in	NULL
control	NULL
and	NULL
leishmania-infected	NULL
cells	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
gamma	NULL
interferon-induced	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
not	NULL
globally	NULL
inhibited	NULL
in	NULL
leishmania-infected	NULL
cells	NULL
indicates	NULL
(	NULL
i	NULL
)	NULL
that	NULL
the	NULL
gamma	NULL
interferon	NULL
receptor	NULL
is	NULL
functionally	NULL
intact	NULL
under	NULL
these	NULL
conditions	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
previously	NULL
published	NULL
findings	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
that	NULL
at	NULL
least	NULL
one	NULL
gamma	NULL
interferon-regulated	NULL
signaling	NULL
pathway	NULL
leading	NULL
to	NULL
changes	NULL
in	NULL
phosphotyrosine	NULL
labeling	NULL
appears	NULL
to	NULL
be	NULL
unimpaired	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
more	NULL
specific	NULL
analysis	NULL
of	NULL
the	NULL
gamma	NULL
interferon	NULL
responsiveness	NULL
of	NULL
Jak-Stat	NULL
signaling	NULL
components	NULL
indicated	NULL
that	NULL
this	NULL
pathway	NULL
is	NULL
selectively	NULL
impaired	NULL
in	NULL
leishmania-infected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
to	NULL
5	NULL
)	NULL
.	NULL

Attenuation	NULL
of	NULL
Jak-Stat	NULL
signaling	NULL
under	NULL
these	NULL
conditions	NULL
appeared	NULL
to	NULL
be	NULL
relatively	NULL
specific	NULL
for	NULL
L.	NULL
donovani	NULL
,	NULL
since	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak2	NULL
and	NULL
phosphorylation	NULL
of	NULL
Stat1	NULL
occurred	NULL
normally	NULL
in	NULL
U-937	NULL
cells	NULL
that	NULL
had	NULL
ingested	NULL
fixed	NULL
S.	NULL
aureus	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
leishmania	NULL
infection	NULL
were	NULL
observed	NULL
to	NULL
be	NULL
time	NULL
dependent	NULL
in	NULL
that	NULL
signaling	NULL
through	NULL
Jak-Stat	NULL
appeared	NULL
to	NULL
be	NULL
intact	NULL
through	NULL
7	NULL
h	NULL
of	NULL
infection	NULL
but	NULL
was	NULL
virtually	NULL
nonexistent	NULL
by	NULL
16	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
infection	NULL
of	NULL
U-937	NULL
cells	NULL
at	NULL
16	NULL
h	NULL
was	NULL
approximately	NULL
twice	NULL
that	NULL
observed	NULL
at	NULL
7	NULL
h.	NULL
Thus	NULL
,	NULL
the	NULL
de-	NULL
LEISHMANIA	NULL
DONOVANI	NULL
AND	NULL
Jak-Statl	NULL
SIGNALING	NULL
4499	NULL
layed	NULL
effect	NULL
of	NULL
L.	NULL
donovani	NULL
on	NULL
the	NULL
Jak-Stat	NULL
pathway	NULL
may	NULL
reflect	NULL
dependency	NULL
on	NULL
the	NULL
level	NULL
of	NULL
infection	NULL
,	NULL
a	NULL
requirement	NULL
for	NULL
synthesis	NULL
of	NULL
an	NULL
inhibitor	NULL
,	NULL
or	NULL
both	NULL
.	NULL

Ongoing	NULL
experiments	NULL
are	NULL
examining	NULL
these	NULL
possibilities	NULL
.	NULL

The	NULL
exact	NULL
basis	NULL
for	NULL
the	NULL
attenuation	NULL
of	NULL
gamma	NULL
interferon-induced	NULL
activation	NULL
of	NULL
the	NULL
Jak-Stat	NULL
signaling	NULL
pathway	NULL
in	NULL
leishmania-infected	NULL
cells	NULL
remains	NULL
to	NULL
be	NULL
defined	NULL
.	NULL

However	NULL
,	NULL
a	NULL
number	NULL
of	NULL
potential	NULL
mechanisms	NULL
may	NULL
be	NULL
considered	NULL
.	NULL

For	NULL
example	NULL
,	NULL
enhanced	NULL
production	NULL
of	NULL
such	NULL
autoinhibitory	NULL
molecules	NULL
as	NULL
interleukin	NULL
10	NULL
,	NULL
transforming	NULL
growth	NULL
factor	NULL
B	NULL
,	NULL
or	NULL
prostaglandins	NULL
by	NULL
infected	NULL
cells	NULL
could	NULL
be	NULL
involved	NULL
.	NULL

Results	NULL
of	NULL
initial	NULL
experiments	NULL
,	NULL
however	NULL
,	NULL
showing	NULL
no	NULL
effects	NULL
of	NULL
either	NULL
transforming	NULL
growth	NULL
factor	NULL
B	NULL
or	NULL
interleukin	NULL
10	NULL
on	NULL
gamma	NULL
interferon-induced	NULL
activation	NULL
of	NULL
the	NULL
Jak-Stat	NULL
pathway	NULL
in	NULL
U-937	NULL
cells	NULL
suggest	NULL
that	NULL
these	NULL
molecules	NULL
may	NULL
not	NULL
be	NULL
relevant	NULL
(	NULL
10a	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
the	NULL
responsiveness	NULL
of	NULL
the	NULL
Jak-Stat	NULL
pathway	NULL
to	NULL
gamma	NULL
interferon	NULL
in	NULL
astrocytes	NULL
was	NULL
also	NULL
observed	NULL
to	NULL
be	NULL
unaffected	NULL
by	NULL
transforming	NULL
growth	NULL
factor	NULL
B	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
Jak-Stat	NULL
signaling	NULL
by	NULL
specific	NULL
ligands	NULL
is	NULL
believed	NULL
to	NULL
involve	NULL
receptor	NULL
dimerization	NULL
or	NULL
oligomerization	NULL
as	NULL
well	NULL
as	NULL
binding	NULL
of	NULL
Jaks	NULL
to	NULL
receptor	NULL
membrane	NULL
proximal	NULL
domains	NULL
(	NULL
5	NULL
)	NULL
.	NULL

While	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
these	NULL
interactions	NULL
could	NULL
be	NULL
disrupted	NULL
by	NULL
leishmania	NULL
infection	NULL
,	NULL
leading	NULL
to	NULL
impaired	NULL
signaling	NULL
,	NULL
it	NULL
seems	NULL
unlikely	NULL
that	NULL
such	NULL
mechanisms	NULL
would	NULL
have	NULL
delayed	NULL
kinetics	NULL
.	NULL

An	NULL
alternative	NULL
mechanism	NULL
to	NULL
explain	NULL
delayed	NULL
attenuation	NULL
of	NULL
Jak-Stat	NULL
activation	NULL
during	NULL
leishmania	NULL
infection	NULL
could	NULL
involve	NULL
induction	NULL
of	NULL
cellular	NULL
phosphotyrosine	NULL
phosphatases	NULL
.	NULL

One	NULL
potential	NULL
candidate	NULL
is	NULL
a	NULL
hematopoietic	NULL
cell	NULL
phosphatase	NULL
(	NULL
known	NULL
otherwise	NULL
as	NULL
PTP1C	NULL
,	NULL
SHP	NULL
,	NULL
or	NULL
SHPTP1	NULL
)	NULL
that	NULL
is	NULL
expressed	NULL
in	NULL
macrophages	NULL
as	NULL
well	NULL
as	NULL
in	NULL
other	NULL
myeloid	NULL
cells	NULL
and	NULL
that	NULL
is	NULL
known	NULL
to	NULL
negatively	NULL
regulate	NULL
Jak-dependent	NULL
signaling	NULL
(	NULL
5	NULL
)	NULL
.	NULL

While	NULL
there	NULL
is	NULL
no	NULL
direct	NULL
support	NULL
for	NULL
this	NULL
possibility	NULL
,	NULL
indirect	NULL
support	NULL
is	NULL
provided	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
at	NULL
least	NULL
two	NULL
dual-specificity	NULL
,	NULL
stress-activated	NULL
phosphoprotein	NULL
phosphatases	NULL
,	NULL
PAC-1	NULL
(	NULL
19	NULL
)	NULL
and	NULL
MKP-1	NULL
(	NULL
6	NULL
)	NULL
,	NULL
are	NULL
induced	NULL
during	NULL
leishmania	NULL
infection	NULL
of	NULL
macrophages	NULL
(	NULL
132	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
results	NULL
of	NULL
the	NULL
present	NULL
study	NULL
provide	NULL
direct	NULL
evidence	NULL
for	NULL
the	NULL
attenuation	NULL
of	NULL
gamma	NULL
interferon-induced	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak2	NULL
and	NULL
phosphorylation	NULL
of	NULL
Statl	NULL
in	NULL
U-937	NULL
cells	NULL
infected	NULL
with	NULL
L.	NULL
donovani	NULL
.	NULL

Evidence	NULL
that	NULL
this	NULL
effect	NULL
is	NULL
selective	NULL
is	NULL
provided	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
gamma	NULL
interferon-induced	NULL
changes	NULL
in	NULL
whole-cell	NULL
tyrosine	NULL
phosphorylation	NULL
are	NULL
not	NULL
impaired	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

This	NULL
result	NULL
also	NULL
implies	NULL
that	NULL
gamma	NULL
interferon-mediated	NULL
cell	NULL
signaling	NULL
in	NULL
mononuclear	NULL
phagocytes	NULL
leading	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
involves	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
in	NULL
addition	NULL
to	NULL
Jak1	NULL
and	NULL
Jak2	NULL
,	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
with	NULL
changes	NULL
in	NULL
their	NULL
activities	NULL
,	NULL
or	NULL
both	NULL
.	NULL

The	NULL
findings	NULL
presented	NULL
also	NULL
suggest	NULL
that	NULL
differentiated	NULL
U-937	NULL
cells	NULL
can	NULL
be	NULL
used	NULL
as	NULL
a	NULL
model	NULL
system	NULL
to	NULL
study	NULL
the	NULL
effects	NULL
of	NULL
infection	NULL
with	NULL
L.	NULL
donovani	NULL
as	NULL
well	NULL
as	NULL
with	NULL
other	NULL
intracellular	NULL
microbes	NULL
on	NULL
gamma	NULL
interferon-regulated	NULL
cell	NULL
signaling	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
infection	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
with	NULL
L.	NULL
donovani	NULL
also	NULL
results	NULL
in	NULL
marked	NULL
attenuation	NULL
of	NULL
the	NULL
gamma	NULL
interferon-induced	NULL
activation	NULL
of	NULL
the	NULL
Jak-Statl	NULL
pathway	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Canada	NULL
grant	NULL
MA-8633	NULL
.	NULL

We	NULL
thank	NULL
Andrew	NULL
Larner	NULL
for	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
antiserum	NULL
to	NULL
Stat1	NULL
,	NULL
Genentech	NULL
Inc.	NULL
for	NULL
providing	NULL
recombinant	NULL
human	NULL
gamma	NULL
interferon	NULL
,	NULL
and	NULL
R.	NULL
Lo	NULL
and	NULL
E.	NULL
Nieto	NULL
for	NULL
advice	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
P.	NULL
Herrera	NULL
for	NULL
critically	NULL
reviewing	NULL
the	NULL
manuscript	NULL
.	NULL

4500	NULL
NANDAN	NULL
AND	NULL
REINER	NULL
INFECT	NULL
.	NULL

ImnmUN	NULL
.	NULL

i	NULL
to	NULL
REFERENCES	NULL
current	NULL
and	NULL
future	NULL
clinical	NULL
applications	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

97:459-467	NULL
.	NULL

Barral	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Barral-Netto	NULL
,	NULL
E.	NULL
C.	NULL
Yong	NULL
,	NULL
C.	NULL
E.	NULL
Brownell	NULL
,	NULL
D.	NULL
R.	NULL
Twardzik	NULL
,	NULL
4ffiNandan	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
N.	NULL
Reiner	NULL
,	NULL
Unpublished	NULL
data	NULL
.	NULL

.	NULL

S.	NULL
G.	NULL
Reed	NULL
.	NULL

1993	NULL
.	NULL

Transforming	NULL
growth	NULL
factor	NULL
B	NULL
as	NULL
a	NULL
virulence	NULL
mechanis	NULL
{	NULL
o	NULL
,	NULL
Nathan	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
R.	NULL
Yoshida	NULL
.	NULL

1988	NULL
.	NULL

Cytokines	NULL
:	NULL
interferon-y	NULL
,	NULL
p.	NULL
229-251	NULL
.	NULL

In	NULL
Leishmania	NULL
braziliensis	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:3442-3446	NULL
.	NULL

J.	NULL
I.	NULL
Gallin	NULL
,	NULL
I.	NULL
M.	NULL
Goldstein	NULL
,	NULL
and	NULL
R.	NULL
Synderman	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Inflammation	NULL
:	NULL
basic	NULL
Cooper	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
D.	NULL
K.	NULL
Dalton	NULL
,	NULL
T.	NULL
A.	NULL
Stewart	NULL
,	NULL
J.	NULL
P.	NULL
Griffin	NULL
,	NULL
D.	NULL
G.	NULL
Russell	NULL
,	NULL
and	NULL
clinical	NULL
correlates	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
Ltd.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

I.	NULL
M.	NULL
Orme	NULL
.	NULL

1993	NULL
.	NULL

Disseminated	NULL
tuberculosis	NULL
in	NULL
interferon	NULL
gamma	NULL
gene	NULL
.	NULL

Olivier	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
G.	NULL
Baimbridge	NULL
,	NULL
and	NULL
N.	NULL
E.	NULL
Reiner	NULL
.	NULL

1992	NULL
.	NULL

Stimulus-response	NULL
disrupted	NULL
mice	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:2243-2247.	NULL
coupling	NULL
in	NULL
monocytes	NULL
infected	NULL
with	NULL
leishmania	NULL
:	NULL
attenuation	NULL
of	NULL
calcium	NULL
tran-Flynn	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
J.	NULL
Chan	NULL
,	NULL
K.	NULL
J.	NULL
Triebold	NULL
,	NULL
D.	NULL
K.	NULL
Dalton	NULL
,	NULL
T.	NULL
A.	NULL
Stewart	NULL
,	NULL
and	NULL
B.	NULL
r.	NULL
sients	NULL
is	NULL
related	NULL
to	NULL
defective	NULL
agonist-induced	NULL
accumulation	NULL
of	NULL
inositol	NULL
phos-Bloom	NULL
.	NULL

1993	NULL
.	NULL

An	NULL
essential	NULL
role	NULL
for	NULL
interferon	NULL
gamma	NULL
in	NULL
resistance	NULL
to	NULL
Myco-Phates	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:1188-1196.	NULL
.	NULL

.	NULL

bacterium	NULL
tuberculosis	NULL
infection	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:2249-2254	NULL
.	NULL

13	NULL
.	NULL

Panek	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Y.-J	NULL
.	NULL

Lee	NULL
,	NULL
and	NULL
E.	NULL
N.	NULL
Benveniste	NULL
.	NULL

1995	NULL
.	NULL

TGF-	NULL
suppression	NULL
of	NULL
Igarashi	NULL
,	NULL
K.-L.	NULL
,	NULL
G.	NULL
Garotta	NULL
,	NULL
L.	NULL
Ozmen	NULL
,	NULL
A.	NULL
Ziemieck	NULL
,	NULL
A.	NULL
F.	NULL
Wilks	NULL
,	NULL
A.	NULL
G.	NULL
IFN-gamma-induced	NULL
class	NULL
II	NULL
MHC	NULL
gene	NULL
expression	NULL
does	NULL
not	NULL
involve	NULL
inhibi-Harpur	NULL
,	NULL
A.	NULL
C.	NULL
Larner	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Finbloom	NULL
.	NULL

1994	NULL
.	NULL

Interferon-y	NULL
induces	NULL
tion	NULL
of	NULL
phosphorylation	NULL
of	NULL
JAK1	NULL
,	NULL
JAK2	NULL
,	NULL
or	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
interferon-r	NULL
receptor	NULL
and	NULL
regulated	NULL
association	NULL
!	NULL

transcription	NULL
,	NULL
or	NULL
modification	NULL
of	NULL
IFN-gamma	NULL
enhanced	NULL
factor	NULL
X	NULL
expres-	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
,	NULL
Jak1	NULL
and	NULL
Jak2	NULL
,	NULL
with	NULL
its	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

Sion	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:610-619	NULL
.	NULL

269:14333-14336	NULL
.	NULL

13a.Reiner	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Unpublished	NULL
data	NULL
.	NULL

5	NULL
.	NULL

Thile	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
K.	NULL
Yamamoto	NULL
,	NULL
and	NULL
O.	NULL
SilvennoinénReiner	NULL
,	NULL
N.	NULL
E.	NULL
1994	NULL
.	NULL

Altered	NULL
cell	NULL
signaling	NULL
and	NULL
mononuclear	NULL
phagocyte	NULL
deac-1995	NULL
.	NULL

Signaling	NULL
through	NULL
the	NULL
hematopoietic	NULL
cytokine	NULL
receptors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

tivation	NULL
during	NULL
intracellular	NULL
infection	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
15:374-381	NULL
.	NULL

Immunol	NULL
.	NULL

13:369-398	NULL
.	NULL

15	NULL
.	NULL

Reiner	NULL
,	NULL
N.	NULL
E.	NULL
,	NULL
and	NULL
C.	NULL
J.	NULL
Malemud	NULL
.	NULL

1985	NULL
.	NULL

Arachidonic	NULL
acid	NULL
metabolism	NULL
by	NULL
6	NULL
.	NULL

Keyse	NULL
,	NULL
S.	NULL
M.	NULL
1995	NULL
.	NULL

An	NULL
emerging	NULL
family	NULL
of	NULL
dual	NULL
specificity	NULL
MAP	NULL
kinase	NULL
murine	NULL
peritoneal	NULL
macrophages	NULL
infected	NULL
with	NULL
Leishmania	NULL
donovani	NULL
:	NULL
in	NULL
vitro	NULL
phosphatases	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
Mol	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

1265:152-160.	NULL
evidence	NULL
for	NULL
parasite-induced	NULL
alterations	NULL
in	NULL
cyclooxygenase	NULL
and	NULL
lipoxygenase	NULL
7	NULL
.	NULL

Kwan	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
W.	NULL
R.	NULL
McMaster	NULL
,	NULL
N.	NULL
Wong	NULL
,	NULL
and	NULL
N.	NULL
E.	NULL
Reiner	NULL
.	NULL

1992	NULL
.	NULL

Inhibitionpathways	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

134:556-563.	NULL
of	NULL
expression	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
Reiner	NULL
,	NULL
N.	NULL
E.	NULL
,	NULL
W.	NULL
Ng	NULL
,	NULL
T.	NULL
Ma	NULL
,	NULL
and	NULL
W.	NULL
R.	NULL
McMaster	NULL
.	NULL

1988	NULL
.	NULL

Kinetics	NULL
of	NULL
inter	NULL
feron-y	NULL
binding	NULL
and	NULL
MHC	NULL
class	NULL
II	NULL
mRNA	NULL
levels	NULL
in	NULL
leishmania-infected	NULL
macrophagesinfected	NULL
with	NULL
Leishmania	NULL
donovani	NULL
occurs	NULL
at	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
macrophages	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:4330-4334.	NULL
transcription	NULL
via	NULL
a	NULL
cyclic	NULL
AMP-independent	NULL
mechanism	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

60	NULL
:	NULL
17	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
1995	NULL
.	NULL

Cytokine	NULL
signaling	NULL
through	NULL
nonreceptor	NULL
protein	NULL
tyrosine	NULL
2115-2120.	NULL
kinases	NULL
.	NULL

Science	NULL
268:251-260	NULL
.	NULL

8	NULL
.	NULL

Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
1970	NULL
.	NULL

Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
18	NULL
.	NULL

Van	NULL
der	NULL
Geer	NULL
,	NULL
P.	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Lindberg	NULL
.	NULL

1994	NULL
.	NULL

Receptor	NULL
protein-the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
227:680-685.	NULL
tyrosine	NULL
kinases	NULL
and	NULL
their	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
9	NULL
.	NULL

Liu	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
R.	NULL
W.	NULL
Brownsey	NULL
,	NULL
and	NULL
N.	NULL
E.	NULL
Reiner	NULL
.	NULL

1994	NULL
.	NULL

Gamma	NULL
interferon	NULL
Biol	NULL
.	NULL

10:251-337.	NULL
induces	NULL
rapid	NULL
and	NULL
coordinate	NULL
activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
19	NULL
.	NULL

Ward	NULL
,	NULL
Y.	NULL
,	NULL
S.	NULL
Gupta	NULL
,	NULL
P.	NULL
Jensen	NULL
,	NULL
M.	NULL
Wartmann	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
and	NULL
K.	NULL
Kelly	NULL
.	NULL

(	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
)	NULL
and	NULL
calcium-independent	NULL
protein	NULL
ki-	NULL
1994	NULL
.	NULL

Control	NULL
of	NULL
MAP	NULL
kinase	NULL
activation	NULL
by	NULL
the	NULL
mitogen-induced	NULL
threonine/	NULL
pase	NULL
C	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

62:2722-2731.	NULL
tyrosine	NULL
phosphatase	NULL
PAC1L	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
367:651-654	NULL
.	NULL

10	NULL
.	NULL

Murray	NULL
,	NULL
H.	NULL
W.	NULL
1994	NULL
.	NULL

Interferon-gamma	NULL
and	NULL
host	NULL
antimicrobial	NULL
defense	NULL
:	NULL
Editor	NULL
:	NULL
J.	NULL
M.	NULL
Mansfield	NULL

